Ensign Peak Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $37.6M | Sell |
|
|||||
|
2025
Q2 | $28.1M | Buy |
|
|||||
|
2025
Q1 | $31.1M | Sell |
|
|||||
|
2024
Q4 | $33.1M | Sell |
|
|||||
|
2024
Q3 | $22.5M | Buy |
|
|||||
|
2024
Q2 | $19.8M | Sell |
|
|||||
|
2024
Q1 | $29.5M | Buy |
|
|||||
|
2023
Q4 | $6.56M | Buy |
|
|||||
|
2023
Q3 | $4.39M | Sell |
|
|||||
|
2023
Q2 | $7.93M | Buy |
|
|||||
|
2023
Q1 | $5.35M | Buy |
|
|||||
|
2022
Q4 | $7.17M | Sell |
|
|||||
|
2022
Q3 | $9.35M | Buy |
|
|||||
|
2022
Q2 | $8.1M | Sell |
|
|||||
|
2022
Q1 | $9.54M | Buy |
|
|||||
|
2021
Q4 | $8.7M | Buy |
|
|||||
|
2021
Q3 | $9.32M | Sell |
|
|||||
|
2021
Q2 | $10.8M | Buy |
|
|||||
|
2021
Q1 | $4.95M | Buy |
|
|||||
|
2020
Q4 | $1.09M | Buy |
|
|||||
|
2020
Q3 | $641K | Buy |
|
|||||
|
2020
Q2 | $227K | Hold |
|
|||||
|
2020
Q1 | $224K | Buy |
|